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ABSTRACT
Exploring the function and 3D space of large
multidomain protein targets often requires
sophisticated experimentation to obtain the
targets in a form suitable for structure determin-
ation. Screening methods capable of selecting
well-expressed, soluble fragments from DNA
libraries exist, but require the use of automation
to maximize chances of picking a few good
candidates. Here, we describe the use of an inser-
tion dihydrofolate reductase (DHFR) vector to select
in-frame fragments and a split-GFP assay technol-
ogy to filter-out constructs that express insoluble
protein fragments. With the incorporation of an
IPCR step to create high density, focused
sublibraries of fragments, this cost-effective
method can be performed manually with no a
priori knowledge of domain boundaries while
permitting single amino acid resolution boundary
mapping. We used it on the well-characterized
p85a subunit of the phosphoinositide-3-kinase to
demonstrate the robustness and efficiency of our
methodology. We then successfully tested it onto
the polyketide synthase PpsC from Mycobacterium
tuberculosis, a potential drug target involved in the
biosynthesis of complex lipids in the cell envelope.
X-ray quality crystals from the acyl-transferase (AT),
dehydratase (DH) and enoyl-reductase (ER) domains
have been obtained.
INTRODUCTION
Over the past 10 years, the Mycobacterium tuberculosis
Structural Genomics Consortium (http://www.doe-mbi
.ucla.edu/TB/), a large-scale center funded by the
National Institutes of General Medical Sciences
(NIGMS), has cloned more than 1400 protein targets for
cell-based production in Escherichia coli. Only half of
the proteins expressed have been produced in a soluble
form. Other structural genomics initiatives also con-
ﬁrmed this step to be one major bottleneck in structural
biology. Screening approaches for improved folding
and stability of protein targets have brought new
insights into solving structures of single-domain proteins
(1,2). However, structure determination of multidomain
proteins has been found to be more challenging due to
their larger size and increased instability. In addition,
domain boundaries are not always straightforward to
predict (3). In this respect, high-throughput approaches
of generating libraries of truncated DNA fragments (4)
combined with a colony ﬁltration immunoblot using
antibody detection of tagged constructs (5,6), the detec-
tion of a ﬂuorescent fused GFP phenotype (7,8) or a
fused C-terminal biotin acceptor peptide (9) have proven
to be successful in identifying constructs potentially
amenable to functional and structural characterization.
Unfortunately, all these approaches lack a ﬁltering
strategy to effectively eliminate DNA fragments, which
do not encode authentic protein domains. Instead, fully
automated strategies have been implemented to effectively
screen the thousands of clones and pick a few good can-
didates (10).
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libraries has become a key step to addressing the construc-
tion of expression plasmid libraries that produce protein
domains in-frame with the target gene. Existing systems
involve expressing fragments as N-terminal fusions to
murine dihydrofolate reductase (mDHFR) (11), kanamy-
cin (12) or b-lactamase (13). However these technologies
yield false positives originating from translation initiation
at internal ribosome binding sites (IRBS). A number of
bipartite selection systems have also been developed in an
attempt to overcome these limitations. In these systems,
the DNA sequence of interest is inserted between the two
halves of the reporter, which are both required to give an
observable phenotype (14–18).
In this article, we describe a novel approach that uses a
two-body E. coli dihydrofolate reductase (DHFR) (19)
scaffold for selecting in-frame DNA sequences from a
random library of a fragmented gene, combined with the
split-GFP technology (20) to identify soluble candidates.
We used the regulatory subunit p85a of the class IA
phosphoinositide 3-kinase (PI3K) as a benchmark to
validate our method. We then tested it onto the polyketide
synthase PpsC from M. tuberculosis. This 230kDa
mega-synthase plays a key role in the virulence of this
microbial pathogen through the synthesis of phtiocerol
dimycocerosates, a family of lipids located in the cell
envelope. With the incorporation of an inverse polymerase
chain reaction (PCR) step to increase population density
in fragments within domains, X-ray quality crystals
from the acyl-transferase (AT), dehydratase (DH) and
enoyl-reductase (ER) domains have been obtained.
MATERIALS AND METHODS
Gene cloning and fragmentation
The p85  and Ppsc genes from M. tuberculosis were cloned
into the NdeI/BamHI and NdeI/SpeI sites of a pET26b
plasmid (Novagen, Madison, WI, USA), respectively, and
PCR ampliﬁed using gene-speciﬁc primers
(Supplementary Data 2). DNA fragmentation conditions
of the p85  gene were optimized using small aliquots of
concentrated PCR products incubated with a serial 2-fold
dilutions of a DNase I stock solution at 1U/ml
(Invitrogen, Carlsbad, CA, USA). Best condition corres-
ponded to a 24-fold dilution from a 1ml stock solution of
DNase I with 20ml of 10mM Tris–Hcl pH=7.4 and 3ml
of 10mg/ml Bovine Serine Albumine (BSA). Cleaned PCR
product of 50ml was mixed with 6ml of 0.5M Tris–Hcl
pH=7.4 and 1ml of 100mM CoCl2. Both solutions
were pre-incubated in a PCR block at 15 C for 5min
before mixing. Two libraries were generated by adding
6ml of the 24-fold DNase I solution to the PCR mixture:
a 250–400bp DNA library (small size) and a 400–750bp
DNA library (large size) with incubation times of 5and
2min, respectively. Digestion reactions were stopped by
adding 650ml of PB buffer before cleaning through a
Qiaquick PCR puriﬁcation column (Qiagen Inc. USA,
Valencia, CA, USA). In the case of Ppsc, small size
(400–850kb) and large size (850–1650kb) DNA libraries
were obtained from 160ml of cleaned PCR product using
a HydroShear device from Genomics Solutions
(Ann Arbor, MI, USA) applying 25 cycles at speed codes
8 and 13, respectively. Extremities of the fragments were
polished using 30-50-exonuclease activity of Vent polymer-
ase (New England Biolabs, Beverly, MA, USA) at 72 C for
20min. Double-stranded DNAs were resolved by agarose
gel electrophoresis and visualized by ethidium bromide
staining. A slab of gel containing DNA fragments with
desired size was then excised and recovered with a
QIAquick gel extraction kit (Qiagen Inc. USA, Valencia,
CA, USA). DNA fragments designed for the screening of
BCR domain constructs were ampliﬁed using gene-speciﬁc
primers (Supplementary Data 2) and ligated into the NdeI/
BamHI of pTET ColE1 GFP 11 vector.
Construction of insertion DHFR library
Blunt fragments were ligated in a StuI-digested insertion
DHFR (iDHFR) pET vector (Supplementary Data 1) for
12h at 16 C, and ligated plasmids were transformed into
electro-competent E. coli DH10B cells (Invitrogen,
Carlsbad, CA, USA) to increase efﬁciency. Starting with
5 106 clones/library, transformed cells were plated onto
Luria-Bertani (LB) agar plates containing 35mg/ml kana-
mycin, allowing the E. coli cells lawn to grow overnight at
37 C. Overnight colonies from lawns of 3 105 clones,
estimated by dilution plates, were washed off and used
for plasmid preparation prior to transformation into
chemically competent E. coli BL21 (DE3) Tuner cells.
Following overnight growth at 32 C on LB/kanamycin
medium, cells were diluted in LB containing 20%
glycerol to OD600nm=1.0 for  80 C freezer stocks.
Forty microliter of the 1.0 OD freezer stock were used
to seed a 3ml LB/kanamycin culture. Cells were
propagated until OD600nm=0.5 was reached, and then
induced with 20mM IPTG for an additional 2–3h. Cells
were diluted in 1ml LB to OD600nm=2.0, yielding
10 108 cells/ml, and plated on LB medium containing
6mg/ml trimethoprim (TMP) and 20mM IPTG. To
compare the colony-forming unit (CFU), numbers in the
presence or absence of TMP, cells were further diluted to
1/16000 and plated out on two LB/agar plates containing
20mM IPTG in the presence or absence of TMP. All plates
were incubated overnight at 32 C.
Inverse PCRs
Recovered iDHFR libraries were diluted for plasmid prep-
aration. NdeI/BamHI and NdeI/SpeI restrictions sites
were used to release fragments from p85  and Ppsc, re-
spectively. Gel extracted and cleaned inserts were ligated
into their corresponding digested pTET ColE1 GFP 11
vector. Inverse PCRs were performed following the
protocol by Hoskins and colleagues (21). For each p85 
and Ppsc targeted domain, phosphorylated forward and
reverse primers were designed (Supplementary Data 2).
Brieﬂy, 100ml inverse PCRs (IPCRs) were conducted
with Phusion DNA polymerase (Finnzymes) according
to the manufacturer’s instructions. Following a
self-ligation with T4 DNA ligase in a 100ml volume at
16 C overnight and a digestion with DpnI enzyme at
37 C for 2h 30min, ligated pTET ColE1 GFP 11
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chemically competent BL21 (DE3) pET GFP 1–10 cells.
Solubility screens using the split-GFP assay
In vivo solubility screenings were performed as previously
described (22). Brieﬂy, cells were grown to saturation in
LB containing 35mg/ml kanamycin and 75mg/ml spectino-
mycin, and diluted in 20% glycerol to OD600nm=1.0 for
 80 C freezer stocks. Frozen cells were thawed at 0 C,
400-fold diluted (twice) in LB and plated onto a nitrocel-
lulose membrane with selective LB-agar containing the
same antibiotics (approximately 3000 colonies). After
overnight growth at 32 C, the membrane was transferred
onto a pre-warmed plate containing 250ng/ml AnTet for
2h, and rested back onto its original LB-Kan-Spec plate
for 1h. Following induction with 1mM IPTG at 37 C for
1h, the induced colonies were illuminated using an
Illumatool Lighting System (LightTools Research),
equipped with a 488nm excitation ﬁlter. An ensemble of
96 clones with decreasing levels of in vivo ﬂuorescence
intensities were picked for each library. Columns 1–3 of
the tissue culture plate correspond to only bright clones,
columns 4–9 present a range in ﬂuorescence intensity
levels from medium bright to faint and columns 10–12
only correspond to very faint clones. As a control, a
total of 96 clones were picked randomly by hand,
transferred to 96-well plates and grown before sequencing.
All the clones were used as starter cultures on 96-well
tissue culture plates for in vitro complementation
split-GFP assays using our in-house automated,
high-throughput, liquid-handling platform (23).
Identiﬁcation of fragments boundaries
Individually picked clones were grown overnight at 30 C
in a 96-well tissue culture plate containing 7.5% glycerol
in LB-Kan-Spec medium. Plasmid ampliﬁcation at the
Los Alamos genome sequencing facility using
rolling-circle ampliﬁcation in the presence of a forward
primer speciﬁc of tet-promoter and a reverse primer
speciﬁc of GFP 11 (Supplementary Data 2) yield
high-quality sequence. DNA sequences were analyzed
using BioEdit software. Sequence alignments were per-
formed by aligning individual fragments onto the
full-length parent gene to determine the exact boundaries
from the forward (start of the fragment) and reverse
sequence (end of the fragment). Based on the in vitro solu-
bility assays, fragments were color-coded black, light
green and bright green, where the black side of the
spectrum identiﬁes the least soluble protein fragments
and the bright green side corresponds to the top 25% of
the most soluble ones. Fraction of color-coded black and
light green fragments varies from 25% and 50% for a
full-length gene mapping to 37.5% in the case of IPCRs.
Small scale expression and solubility tests
An ensemble of 10 fragments spanning the PpsC polypep-
tide chain were selected and subcloned from the
pTET-GFP, 11 plasmid into a N6–HIS or C6–HIS pET
vector. The resulting clones were grown at 37 Ci n1 m l
cultures using 35mg/ml kananycin. Cells were induced in
exponential phase with 1mM IPTG for 3h. Cell culture
pellets of 1ml of each fragment were separately resus-
pended in 40ml 150mM NaCl, 100mM Tris–HCl
pH=7.5, 10% (v/v) glycerol (TNG buffer) and sonicated.
The lysate was fractionated by centrifugation to yield the
soluble and pellet fractions. The pellet fraction was
washed twice with 100ml TNG, centrifuged and resus-
pended in the same starting volume. Samples correspond-
ing to the soluble (S) and pellet (P) fractions were resolved
on a 4–20% gradient Criterion SDS–PAGE gel (Bio-Rad,
Hercules, CA, USA). Protein samples were stained using
Gel Code Blue stain reagent (Pierce, Rockford, IL) and
imaged using a GS-800 Calibrated Densitometer (Biorad,
Hercules, CA, USA).
Metal afﬁnity resin puriﬁcation of selected fragments
Five hundred milliliter cultures of BL21(DE3) cells ex-
pressing selected protein fragments were grown to OD
(600nm)  0.5–0.7 in LB medium supplemented with
1mM kanamycin, induced with 0.5mM IPTG for 5h at
32 C, pelleted by centrifugation, resuspended in 15ml
100mM Tris–Hcl pH=8.1 containing 150mM NaCl
and sonicated. The soluble extract of 15ml was mixed
with an equal volume of 50% v/v slurry of metal afﬁnity
resin beads (Talon resin, Clontech, Palo Alto, CA, USA)
in TNG buffer for 10min and centrifuged brieﬂy. The
unbound fraction was removed by pipetting and the
beads were washed twice with 10volumes of TNG
loading buffer. After an additional wash with TNG
buffer supplemented with 10mM imidazole, His-tagged
proteins were eluted with 250mM imidazole in TNG
buffer. For each puriﬁcation step, the proteins elution
samples were resolved on a 4–20% gradient Criterion
SDS–PAGE gel (Bio-Rad, Hercules, CA, USA) and
stained using the same procedure described above. Using
this procedure, 98% pure AT ( 4mg), DH ( 20mg) and
ER ( 5mg) proteins were obtained. The absence of ag-
gregates in the samples and polydispersity levels of <10%
were conﬁrmed using a DynaPro
TM Dynamic Light
Scattering (DLS) Instrument from Wyatt Technology.
15N–Protein labeling and sample preparation for
NMR spectroscopy
Protein expression level in minimal media was enhanced
by increasing cell density using a 4:1 cell concentrating
method (24). For
15N uniform labeling, cells from 2l of
LB media were grown at 37 C until an OD600 of 0.5–0.7
was reached, then harvested and resuspended in 500ml of
M9 minimal media containing 0.5g
15NH4Cl. Following
an additional 30min of shaking, cells were induced with
0.5mM IPTG for 7h at 25 C. Proteins were puriﬁed as
described above using Talon resin and dialyzed against
50mM Na phosphate buffer pH=7, 1mM DTT, 1mM
EDTA overnight at 4 C to remove imidazole and salt
from elution buffer. Protein solution was concentrated
using an Amicon Ultra-15 centrifugal ﬁlter device
(10kDa cutoff; Millipore). Final NMR samples usually
contain 0.5–1mM protein in 50mM Na phosphate
buffer pH=7, 1mM DTT, 1mM EDTA and 10%
D2O.
1H–
15N HSQC spectra were recorded at 298K on
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probe. Complex points of 1024 in the direct dimension
(
1H) and 256 complex points in the indirect dimension
(
15N) were collected. All spectra were processed using
nmrPipe (25) and analyzed by the Sparky software
(Goddard and Kneller, University of California, San
Francisco). Chemical shifts were referenced to 4,4-
dimethyl-4-silapentane-1-sulfonic acid (26).
RESULTS
Selection of in-frame, well-expressed and soluble
fragments
Our strategy has four distinct steps, where selection
pressure forces the false positives at any given step to be
effectively eliminated and the number of false negatives to
be reduced. First, a library of 5 106 clones expressing
DNA fragments is created by fragmentation of a PCR
ampliﬁed gene using DNase I or mechanical shearing
(Figure 1). Fragments of the desired size are excised
from preparative agarose gel, blunt-ended with
50-30-exonuclease, and then cloned between the two
halves of bacterial DHFR at a permissive site between
amino acids 86 and 87 in the presence of TMP
(Supplementary Data 1). We found that 3–6mg/ml TMP
killed DH10B E. coli cells, but allowed clones expressing
inserts without stop codons to subsist. Under this selective
antibiotic pressure, approximately 1 in 18 cells survive,
corresponding to fragments translated in the same
reading frame as the parent open reading frame (ORF)
and in-frame with the reporter destination vector (8).
This leads to 3 105 clones recovered at this step
(Figure 1), a number to compare with the few hundreds
in-frame clones from published methods (5,6,11). Only
fully automated platforms capable of picking and
assaying tens of thousands of clones in parallel for expres-
sion and solubility can compete with our approach. In this
respect, Expression of Soluble Proteins by Random
Incremental Truncation (ESPRIT) (9) has led to remark-
able results on several challenging targets (10,27–30). In
the third step, in-frame fragments are subcloned into the
split-GFP system. At this point, full-length libraries can be
screened for solubility after in vivo sequential induction of
the GFP 11-tagged protein fragments and the complemen-
tary GFP 1–10 detector (22). Clones displaying a wide
Figure 1. The GFP-enabled domain trapping strategy. The PCR-ampliﬁed gene is fragmented by chemical or mechanical means and DNA fragments
of desired size are excised from agarose gel. Blunt-end fragments are cloned into the iDHFR ORF ﬁlter, where only the in-frame ones permitting the
expression of the second half of DHFR will survive. Inserts from the recovered plasmids are cloned into the split-GFP vector and used for IPCR to
create high density, focused sublibraries of fragments prior to the split-GFP assay. A range of ﬂuorescent clones are picked and grown in 96-well
liquid cultures for in vitro quantiﬁcation of the soluble and insoluble protein fractions. Clones are sequenced and the fragments are aligned onto the
full parent gene. Fragments can be directly tested for expression or subcloned without the S11 tag into a pET vector. Numbers to the left indicate the
approximate library size at the different steps.
e125 Nucleic Acids Research, 2011,Vol.39, No. 18 PAGE 4 OF 11range of ﬂuorescence are picked from the agar plates and
grown in 96-well liquid culture plates (Figure 2). Within
each library, we picked a total of 384 clones in four 96-well
plates with ﬂuorescence intensity levels from bright to
faint (see Methods in Supplementary Data). As an alter-
native, IPCR (21) can ﬁrst be used to create high density,
focused sublibraries of fragments prior to the split-GFP
assay. In this case, 96 clones were picked per sublibrary of
fragments to ensure maximum coverage (Figure 1). For
in vitro quantiﬁcation, E. coli cells were ﬁrst induced with
anhydrotetracycline (AnTET) to overexpress the GFP
11-tagged proteins. Soluble lysates and insoluble fractions
were assayed by adding the GFP 1–10 detector fragment,
as previously described (22). In the ﬁnal step, DNA
sequencing was used to determine the boundaries of
each fragment by reference to the parent gene. In silico,
all fragment sequences within a library were aligned onto
the parent gene and color-coded by solubility levels.
We used the color scheme black/light green/bright
green, where the black side of the spectrum identiﬁes the
least soluble fragments and the bright-green color
identiﬁes the most soluble ones. This provides a visual
tool to correlate fragment boundaries with solubility
levels and makes it easy to identify the most compact
and soluble fragments for downstream functional and
structural characterization.
p85a as a benchmark for testing our domain
trapping strategy
The structural organization of the regulatory subunit p85a
of the class IA PI3K has been very well studied. Except for
the two coiled-coil regions CC1 and CC2, the documented
structures of the well-folded SH3 (31), BCR (32), N–SH2
(33) and C–SH2 (34) make p85a a good benchmark for
demonstrating the feasibility and efﬁciency of domain
trapping strategies.
Large quantities of PCR ampliﬁed target DNA (1–2mg)
were produced using either the Platinum Taq DNA
Polymerase High Fidelity (Invitrogen, Carlsbad, CA,
USA) or the Phusion High-Fidelity DNA polymerase
(NEB, Ipswich, MA, USA). Since DNA ligation efﬁciency
varies inversely with the size of the insert, and to avoid
biased ligation of small fragments, two individual libraries
of fragments were created: from 250to 500bp and from
350 to 750bp. Indeed, the larger size fragment library
would let us ‘ﬁsh’ soluble fragments encompassing the
larger BCR domain (550bp), whereas the smaller size
fragment library would favor the selection of smaller
soluble fragments from the SH3 domain (252bp) and
the two SH2 domains (345and 324bp for N–SH2 and
C–SH2, respectively). DNase I reaction conditions were
optimized to narrow the window of highly concentrated
DNA fragments in the desired size range (see Methods in
Supplementary Data).
Figure 2. Screening clones using the split-GFP reassembly assay. Images showing cell colony ﬂuorescence from agar plates after sequential induction
(solubility reporter) and co-induction (expression reporter) of the GFP 11-tagged protein fragments and its complementary GFP 1–10 detector.
Clones displaying a wide range of ﬂuorescence are visible after sequential induction.
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were cloned into the iDHFR vector and transformed into
E. coli DH10B electro-competent cells (Invitrogen,
Carlsbad, CA, USA). Transformation of the recovered
plasmids into E. coli BL21 Tuner
TM(DE3) competent
cells (Novagen, San Diego, CA, USA) containing the
lacY permease mutation allowed the uniform induction
of the cells by IPTG during the subsequent selection of
in-frame clones. To ensure that the selection process is
consistent with the theoretical 1 in 18 clones expected to
survive after the ORF-ﬁlter step, each library was diluted
and plated on medium in the presence and absence of
TMP for fast and accurate colony counting.
Initially, pools of ‘in-frame’ DNA fragments were
subcloned into the pTET-GFP 11 solubility vector using
NdeI and BamHI sites (Supplementary Data 1), and
transformed into BL21 (DE3) cells containing the pET
GFP 1–10 plasmid to screen for soluble expression (20).
After sequential induction of the GFP 11-tagged frag-
ments, we could take advantage of the split-GFP comple-
mentation assay to screen thousands of clones in vivo by
visual assessment of their intrinsic ﬂuorescence, which is
well correlated with the amount of soluble protein ex-
pressed (Figure 2). Both fragment libraries displayed sub-
stantial phenotypic variability as observed from the wide
distribution of ﬂuorescence intensities. Even though
sequencing information was missing for some of the 384
manually picked clones (79 for the small size and 16 for
the large size library), probably due to cross contamin-
ation with nearby faint or black clones, only a limited
number of the sequenced fragments were not in the au-
thentic reading frame (9 out of 305 for the small size and
2 out of 368 for the large size library), thus illustrating the
efﬁciency of selection process. Despite the fact that most
p85a domains are well represented, with the exception of
the BCR domain, we noticed a bias in the distribution of
fragments towards the second-half of the gene, from the
N–SH2 domain to the C-terminal end of the gene
(Supplementary Figure S1). In contrast, the distribution
of randomly picked fragments is more homogeneous, as
no information concerning ﬂuorescence intensity levels
was taken into consideration (data not shown).
Figure 3. Mapping of the IPCR p85a targeted fragments. IPCRs using oppositely directed primers were used to generate sublibraries of fragments.
For each sublibrary, an ensemble of 96 clones with a wide range of in vivo ﬂuorescence intensities were picked and grown in 96-well liquid culture
plates for in vitro split-GFP solubility screen. Only the correctly sequenced in-frame fragments are represented. Based on the in vitro solubility assays,
fragments were color-coded black, light green and bright green, where the black side of the spectrum identiﬁes the bottom 20% least soluble protein
fragments and the bright green side corresponds to the top 20% most soluble ones. IPCRs within p85a were used to generate four large-size
sublibraries (350–750kb) centered onto the SH3, BCR, N–SH2 and C–SH2 domains. Within each library, solubility values from three or more
identical fragments were averaged in order to keep the color-coded representation as clear as possible. Boundaries of structure solved domains are
indicated in red and the junction at amino acid position 9 is indicated in blue.
e125 Nucleic Acids Research, 2011,Vol.39, No. 18 PAGE 6 OF 11We reasoned that the bias may originate from our
multistep selection process that favors the selection of ex-
tremely well-behaved fragments to the detriment of less
soluble ones. To circumvent this representation artifact
and starting with the same original library of in-frame
fragments (following iDHFR selection), we used the
IPCR (21) technique to selectively enrich for DNA se-
quences in regions of p85 . Phosphorylated primers were
designed (Supplementary Data 2) to generate three
small-size sublibraries (250–400bp) centered on the SH3,
N–SH2 and C–SH2 domains and one large-size sublibrary
(400–750bp) centered onto the BCR domain (Figure 3).
We noticed that cutting into the N-terminal region of the
SH3 and N–SH2 domains had a dramatic effect onto the
solubility levels of the selected fragments. Also, the in-
corporation of amino acid residues from the CC2
domain and linker region drastically improved the solu-
bility of the C–SH2 centered fragments, a somewhat
surprising and difﬁcult result to predict considering the
unstructured nature of these regions.
Fragments can occasionally be used as a starting point
to identify more compact and soluble constructs with a
clear objective of maximizing the chances of 3D structure
(35). As illustrated in Figure 3, IPCR sublibrary centered
on the BCR domain contains three soluble fragments
(110–294, 110–297 and 110–300) with C-terminal positions
slightly shorter than the structurally characterized frag-
ments 105–319 (PDB code: 1PBW). We note that the
low solubility of another BCR fragment (117–297) from
the full-length p85  library could be attributed to its
shorter N-terminal end (Supplementary Figure S1b). In
an effort to rationalize the effect of N- and C-terminal
truncations in the BCR region, we cloned an ensemble
of 144 constructs corresponding to a 10 amino acids
walk from positions 55 and 369 (Figure 4 and
Supplementary Data 2). Protein solubility levels were
assessed both in vivo and in vitro using the split-GFP
assay (20). Figure 4 illustrates the expression and solubil-
ity levels of all 144 constructs, respectively. As expected,
fragments are soluble when the BCR core domain is
Figure 4. PCR-directed truncations of the p85a BCR domain. (a) Schematic representation of all 144 constructs aligned onto the p85a amino-acid
sequence. N- and C-terminal positions are indicated. Fragments are organized in groups of 12 with identical N-terminal positions. (b) Expression
(left) and solubility (right) levels of E. coli BL21(DE3) cells expressing the corresponding fragments in fusion with S11 following complementation
with GFP 1–10. Orange dashed lines mark boundaries, where dramatic changes in expression and solubility levels were observed. (c) In addition to
105–319 for which the X-ray structure is known (PDB code: 1PBW), well-expressed and soluble fragments were selected for downstream NMR
studies. HSQC spectra of fragments 105–299 (blue), 105–309 (red), 105–319 (black with corresponding white rectangle in the solubility screen) and
115–299 (green) are represented.
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solubility levels fall. Approximate boundaries of soluble
fragments range between positions 115 and 125 in the
N-terminal region, and positions 289 and 299 in the
C-terminal region. A ﬁner screening using one amino
acid incremental truncation from the N-terminal
(116–123) and C-terminal (290–297) regions was then per-
formed (Supplementary Figure S2). Based on the ﬂuores-
cence intensity ratios of solubility over expression, the
fragments 116–294 is the shortest most soluble fragment
of the BCR domain. Interestingly, cutting into the
C-terminal end of helix a10, from positions 297 to 294,
did not seem to have an effect on the solubility of the last
three fragments within the group. The addition of a three
residue linker (Gly–Ser–Asp) to the C-terminus of the
protein as a result of molecular cloning site in the
pTET-GFP 11 (20) vector may compensate for residues
Ser–Thr–Glu of the real protein sequence, thus making
truncated variants more stable. A total of six most
compact soluble protein fragments, including the structur-
ally characterized fragments 105–319 (PDB code: 1PBW),
were selected and puriﬁed for 2D NMR experiments.
1H–
15N HSQC spectra are well resolved and dispersed,
thus indicating that all protein fragments are well folded
(Figure 4c and Supplementary Figure S2). These spectra
overlay each other, thus suggesting that the extra tails at
both N- and C-terminal ends do not affect the domain
core structure.
Application to the polyketide synthase PpsC from
M. tuberculosis
Polyketides comprise natural compounds that are essen-
tial for the virulence of major human mycobacterial
pathogens, namely M. tuberculosis (36,37) and other
emerging infectious agents. Polyketide biosynthesis is ac-
complished by polyketide synthases (PKS), which are
giant and multifunctional enzymes. PpsC belongs to the
family of type I PKS with six domains present on a single
polypeptide chain.
Information on the 3D structure of full-length
type I PKS is not available and the current data col-
lected worldwide on fatty acid synthases (FAS) and the
6-deoxyerythronolide B synthase (DEBS) from
Saccharopolyspora erythraea, the most studied modular
PKS, only allow rough modeling of their molecular archi-
tectures, thus providing only a low-resolution picture.
High-resolution structural information is needed to
describe at the atomic level each individual domain in
order to understand the full-length PKS catalytic machin-
ery. Dedicated software for the analysis of PKS, MAPSI
Figure 5. Mapping of the IPCR PpsC targeted fragments. Five large-size sublibraries of fragments (850–1650kb) centered onto the KS, AT, DH, ER
and ACP domains were generated. Picking and color coding of fragments follow the same rules as in Figure 3. Red dots indicate the fragments
selected for downstream biochemical and structural characterization.
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and SEARCHPKS (http://www.nii.res.in/searchpks.html)
were used to identify approximate boundaries for each
individual domain. Only in the case of the DH domain,
the identiﬁcation of C-terminal boundaries differs sub-
stantially for the methods used in the two approaches
(1093 with SEARCHPKS and 1221 with MAPSI).
We used a hydrodynamic point-sink shearing method
(38) to create large-size (850–1650kb) DNA libraries of
Ppsc fragments. Compared to enzymatic digestion with
DNase I, the resulting DNA fragment libraries were
tightly distributed in size (data not shown). For each
targeted domain, IPCR was used to generate focused
sublibraries of fragments, as shown in Figure 5. Initially,
phosphorylated forward and reverse IPCR primers were
designed to the center of the KS, AT, DH, ER and ACP
domains (Supplementary Data 1). Multiple priming sites
originating from the high GC content of the M. tubercu-
losis genome lead to PCR ampliﬁcation failures. To cir-
cumvent this problem, 32-mer primers were blasted
against the full-length gene to ensure priming at a
unique site. An ensemble of 10 fragments covering all
six PpsC domains was selected (Figure 6a) and subcloned
from a pTET-GFP 11 vector using NdeI and SpeI sites
(Supplementary Data 1) into a N6–HIS pET vector.
Selected fragments had to satisfy two main criteria:
(i) N- and C-terminal boundaries should incorporate the
predicted ones and (ii) fragments with different levels of
solubility should be considered if possible. SDS–PAGE of
the soluble and pellet fractions of E. coli BL21 (DE3) cells,
expressing the different fragments, were in good agree-
ment with the in vitro split-GFP solubility screen
(Figure 6b). Crystallization trials have been performed
on 6 out of 10 selected constructs centered on the AT,
DH and ER domains. Diffraction quality crystals have
been obtained for all three domains (Figure 6c).
Analysis of the 3D structure of the fragment 921–1222
centered onto the DH domain clearly indicates that the
typical double-hotdog fold extends from positions 933 to
1216 (A. Faille et al., manuscript in preparation).
DISCUSSION
Our approach to screening libraries of over a million
clones can be of general interest for identifying soluble
constructs of ‘recalcitrant’ proteins, as it does not
require the use of an automated robotic platform. It
simply relies on well-proven technologies capable of ef-
fectively eliminating the unwanted constructs, thus
reducing the population size of fragments to be
analysed. Although E. coli cells expressing self-associated
DHFR in the presence of TMP somewhat forces the se-
lection of inserted in-frame fragments, we noticed the
presence of short antisense peptides devoid of stop
codons and in-frame with both ends of DHFR.
Following the in vivo split-GFP ﬁltration step, the propor-
tion of false positives drops to <3% of the total number of
picked clones. The most plausible explanation is that they
Figure 6. Expression, solubility and crystallization trials of selected PpsC fragments. (a) Ten fragments covering the structural domains of PpsC were
subcloned from the pTET-GFP 11 plasmid into a N6–HIS pET vector for biochemical and biophysical characterization. (b) SDS–PAGE of soluble
(S) and pellet (P) fractions of E. coli BL21 (DE3) cells expressing the different fragments. (c) Pictures of X-ray quality crystals of selected fragments
represented as a black rectangle in (a) are shown. The 3D structures of the AT (545–877), DH (921–1222), and truncated ER (1558–1750) domains
have been recently determined at 1.8, 2.8, and 2.5 A ˚ resolutions, respectively.
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subcloning into the GFP S11 vector.
The IPCR step is crucial as it helps remove the bias
originating from the overrepresentation of regions of the
protein that never get ampliﬁed due to the lack of
homology to the IPCR primers. It also permits single
amino acid resolution boundary mapping as seen from
both p85a and PpsC sublibraries of fragments. For
example, in the case of the p85a SH3 domain, two
distinct populations of fragments at the junction between
amino acid positions 6 and 9 were visible (Figure 3).
Detailed examination of the solution structure of the
SH3 domain (31) revealed that Tyr6 is the last amino
acid residue of the N-terminal tail that connects to a
four-residues b-strand central to a triple-stranded antipar-
allel b-sheet. Cutting into this strand would not only have
a destabilizing effect on interactions within the b-sheet,
but also with a parallel b-sheet of two strands crossing
at right angle. In the case of PpsC, single amino acid trun-
cations also have a dramatic impact on the solubility of
the expressed fragments, a result which clearly demon-
strates the potential of our approach in an attempt to
identify potential candidates for downstream functional
and structural applications. To date, only the crystal struc-
ture of a fragment covering partially the ER domain has
been reported (PDB code 1PQW). Thanks to our
approach, we successfully crystallized fragments encom-
passing the AT, DH and ER domains and solved the
X-ray structure of the active AT and DH domains
(Alexandre Faille et al, manuscripts in preparation).
Our domain trapping strategy is also particularly well
adapted to situations, where unstructured regions are es-
sentials for the stability of isolated domains. As seen with
p85a and PpsC, it offers a rapid and easy way to identify
N- and C-terminal boundaries of soluble fragments often
difﬁcult to predict solely by theoretical means. In the near
future, we anticipate our approach will facilitate decipher
structure–function relationships in mechanistically diverse
and complex enzymatic machineries, thus opening the way
to atomic level description of active sites and domain–
domain interactions.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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